Skip to main content
Contemporary Oncology logoLink to Contemporary Oncology
. 2012 Nov 20;16(5):444–446. doi: 10.5114/wo.2012.31777

Atypical dissemination of lung cancer to the adrenal gland and to the spleen

Marek Chorąży 1,, Marta Majcher 1, Katarzyna Fedyszyn-Urbanowicz 1, Grażyna Bierzyńska-Macyszyn 2, Robert Kwiatkowski 3
PMCID: PMC3687445  PMID: 23788926

Abstract

Metastases of lung cancer to such organs as the liver, bones or to the central nervous system appear to be a frequent complication of this disease. At the same time, metastases to the adrenal gland are found less frequently. Metastases of lung cancer to the spleen are a great rarity and they are described sporadically. Our report presents a unique case of left lung cancer with simultaneous metastases to the adrenal gland and to the spleen. All the presented lesions were diagnosed by ultrasound guided biopsy and confirmed by histopathological examination.

The patient received combined chemoradiotherapy. She was closely monitored over an 18-month observation period following treatment. No new metastases were reported.

Keywords: lung cancer diagnosis, ultrasound guided fine-needle biopsy, metastasis to the adrenal gland, metastasis to the spleen

Introduction

Metastases to organs such as the liver, bones or central nervous system appear to be a frequent complication of lung cancer, whereas metastases to the suprarenal glands are found less frequently [1]. Metastases of lung cancer to the spleen are a great rarity and they are described sporadically [2].

An adrenal gland tumor detected incidentally during imaging tests is described as an incidentaloma [37].

Splenic lesions are most often incidentally detected on imaging tests requested for other conditions. Primary spleen tumors are extremely rare [8]. Primary cysts acquiring enormous proportions and hemangiomas are classified as benign tumors [9, 10]. Metastatic lesions and inflammatory pseudotumors may also be seen, but only very rarely and usually as casuistry [11, 12]. Splenic lesions may be observed in the course of malignant lymphoma [13, 14]. Lesions characteristic of sclerosing angiomatoid nodular transformation (SANT) have also been described [15].

In most cases, the typical characteristics of splenic tumors are established on the basis of histopathological findings, which are obtained by the surgical removal of the tumor or by post-mortem examination [8, 10, 1618].

Metastases to the adrenal gland are also rare. This work presents a case of simultaneous dissemination of lung cancer to the adrenal gland and to the spleen.

Material and methods

A female patient (age 74) was sent from a hospital in Zawiercie for further investigations and management of a left lung tumor lesion discovered during X-ray examination. Chest surgeons had rejected her from an invasive therapy. However, bronchoscopy was performed and revealed no evidence of pathological bronchial lesions. In this situation the patient was sent to our hospital for the purpose of making the histopathological diagnosis (History No. 16735/877/09).

Computed tomography (CT) scan showed chest infiltration situated peripherally in the left lung. After establishing the distance, place and depth of the puncture by using CT (Fig. 1), the parietal tumor was visualized by ultrasound and a biopsy was performed. We performed an ultrasound-guided (free hand technique) fine-needle biopsy of the lesion using a Hitachi EUS 515 sonographic machine (Fig. 2). The procedure was performed under local anesthesia; no complications were recorded.

Fig. 1.

Fig. 1

Computed tomography imaging scan – establishing the distance, place and depth of the puncture

Fig. 2.

Fig. 2

Ultrasound imaging scan – wall located left lung tumor – biopsy needle

The ultrasound examination of the abdomen revealed a pathological mass in the spleen and in the left adrenal gland (Fig. 3). We also performed in local anesthesia an ultrasound-guided (free hand technique) fine-needle biopsy of these lesions.

Fig. 3.

Fig. 3

Ultrasound imaging scan – small cell cancer metastasis to left adrenal gland and spleen

Results and discussion

In our case small cell lung cancer was detected in the percutaneous biopsy of the left lung. The same type of cancer as in the left lung was observed in both the adrenal gland and in the spleen (metastases of small cell cancer).

Imaging methods available to us showed no evidence of cancer metastases in other organs.

In the existing literature, we found only a few cases of lung cancer metastases to the spleen [2, 17, 18]. There are also some descriptions of metastases isolated in spleen from other organs [16]. Simultaneous metastases of lung cancer to the adrenal gland and the spleen have never been described.

The case presented above shows that the metastatic lesion can sometimes be an accessible place to collect tissue for diagnosing the cancer pattern of the primary cancer site. The case is exceptional because the spleen is an organ where lung cancer metastases are not frequently found, while metastases to the adrenal gland alone are common. More often, metastases are observed in the liver. The case is also unique because the adrenal gland and the spleen are organs where finding concurrent metastases of lung cancer is very rare.

The patient received combined chemoradiotherapy. She was closely monitored over an 18-month observation period following treatment. No new metastases were reported.

The authors declare no conflict of interest.

References

  • 1.Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, Sturgeon C. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer. 2008;113:3130–6. doi: 10.1002/cncr.23886. [DOI] [PubMed] [Google Scholar]
  • 2.Van Hul I, Cools P, Rutsaert R. Solitary splenic metastasis of an adenocarcinoma of the lung 2 years postoperatively. Acta Chir Belg. 2008;108:462–3. doi: 10.1080/00015458.2008.11680265. [DOI] [PubMed] [Google Scholar]
  • 3.Al-Hawary MM, Francis IR, Korobkin M. Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab. 2005;19:277–92. doi: 10.1016/j.beem.2004.09.002. [DOI] [PubMed] [Google Scholar]
  • 4.Hennings J, Hellman P, Ahlström H, Sundin A. Computed tomography, magnetic resonance imaging, and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas. Eur J Radiol. 2009;69:314–23. doi: 10.1016/j.ejrad.2007.10.024. [DOI] [PubMed] [Google Scholar]
  • 5.Johnson PT, Horton KM, Fishman EK. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics. 2009;29:1333–51. doi: 10.1148/rg.295095027. [DOI] [PubMed] [Google Scholar]
  • 6.Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinical inapparent adrenal mass (“incidentaloma”) Ann Intern Med. 2003;138:424–9. doi: 10.7326/0003-4819-138-5-200303040-00013. [DOI] [PubMed] [Google Scholar]
  • 7.Terzolo M, Bovio S, Pia A, Reimondo G, Angeli A. Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab. 2009;23:233–43. doi: 10.1016/j.beem.2009.04.001. [DOI] [PubMed] [Google Scholar]
  • 8.Kochar K, Vijayasekar C, Pandey U, Bhogal R, Brown L, Mathew G. Primary carcinosarcoma of spleen: case report of a rare tumor and review of the literature. Int J Surg Pathol. 2009;17:72–7. doi: 10.1177/1066896908316070. [DOI] [PubMed] [Google Scholar]
  • 9.Lee H, Maeda K. Hamartoma of the spleen. Arch Pathol Lab Med. 2009;133:147–51. doi: 10.5858/133.1.147. [DOI] [PubMed] [Google Scholar]
  • 10.Orawczyk T, Ćwik P, Ziaja D, Kazibudzki M. Familia lymphangioma – a rare form of splenic cysts. Chir Pol. 2002;4:187–91. [Google Scholar]
  • 11.Bhatt S, Simon R, Dogra VS. Radiologic-pathologic conferences of the University of Rochester School of Medicine: inflammatory pseudotumors of the spleen. AJR Am J Roentgenol. 2008;191:1477–9. doi: 10.2214/AJR.08.1011. [DOI] [PubMed] [Google Scholar]
  • 12.Tee M, Vos P, Zetler P, Wiseman SM. Incidental littoral cell angioma of the spleen. World J Surg Oncol. 2008;6:87–92. doi: 10.1186/1477-7819-6-87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gupta R, Naseem S, Sukumaran S, Kashyap R, Kaur S, Paul L. Splenic lymphoma with villous lymphocytes. Indian J Pathol Microbiol. 2008;51:113–5. doi: 10.4103/0377-4929.40420. [DOI] [PubMed] [Google Scholar]
  • 14.Takata F, Kaida H, Ishibashi M, et al. Primary splenic lymphoma detected by F-18 FDG PET. Clin Nucl Med. 2008;33:204–7. doi: 10.1097/RLU.0b013e318162dd74. [DOI] [PubMed] [Google Scholar]
  • 15.Koreishi AF, Saenz AJ, Fleming SE, Teruya-Feldstein J. Sclerosing angiomatoid nodular transformation (SANT) of the spleen: a report of 3 cases. Int J Surg Pathol. 2010;18:S136–41. doi: 10.1177/1066896909342568. [DOI] [PubMed] [Google Scholar]
  • 16.Showalter SL, Hager E, Yeo CJ. Metastatic disease to the pancreas and spleen. Semin Oncol. 2008;35:160–71. doi: 10.1053/j.seminoncol.2007.12.008. [DOI] [PubMed] [Google Scholar]
  • 17.Kinoshita A, Nakano M, Fukuda M, et al. Splenic metastasis from lung cancer. Neth J Med. 1995;47:219–23. doi: 10.1016/0300-2977(95)00011-8. [DOI] [PubMed] [Google Scholar]
  • 18.Dias AR, Pinto RA, Ravanini JN, Lupinacci RM, Cecconello I, Ribeiro U., Jr Isolated splenic metastasis from lung squamous cell carcinoma. World J Surg Oncol. 2012;10:24. doi: 10.1186/1477-7819-10-24. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Contemporary Oncology are provided here courtesy of Termedia Publishing

RESOURCES